Benzinga

Benzinga

Benzinga

jueves, agosto 27

CME Group Inc

CMENASDAQ
Trade with Public
Trade with Public
$280.94
-0.04-0.01%
al cierre: Aug 27, 5:00 PM EST
$279.42
-1.52-0.54%
After hour: 4:27 PM EST
Dividendo: La fecha límite del dividendo es dentro de 13 días
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

CME Group Analyst Price Targets

Wall Street analyst price targets and consensus rating for CME Group (CME).

Price Target Range — 9 Quarters

Analyst Consensus — 17 Analysts

8Buy
6Hold
3Sell
Consensus RatingOutperform# Analysts17Avg. Consensus PT$278Upside to Avg. PT-0.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 19, 2026Deutsche BankBrian BedellDowngradeBuy→Hold$286→$270
Jul 23, 2026JP MorganKenneth WorthingtonPT RaiseUnderweight$249→$250
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Deutsche Bank Downgrades CME Group to Hold, Lowers Price Target to $270

Deutsche Bank analyst Brian Bedell downgrades CME Group (NASDAQ:CME) from Buy to Hold and lowers the price target from $286 to $270.
Benzinga Newsdesk

PRO
B of A Securities Maintains Underperform on CME Group, Raises Price Target to $230

B of A Securities analyst Craig Siegenthaler maintains CME Group (NASDAQ:CME) with a Underperform and raises the price target from $226 to $230.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $330

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $324 to $330.
Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on CME Group, Lowers Price Target to $295

Piper Sandler analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $329 to $295.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on CME Group, Lowers Price Target to $324

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and lowers the price target from $353 to $324.
Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on CME Group, Lowers Price Target to $270

Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and lowers the price target from $316 to $270.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved